More From The Market Online
Percheron Therapeutics completes cancer treatment drug substance manufacture milestone
Percheron Therapeutics has achieved a major milestone in the commercial development of its lead candidate HMBD-002.
- Colin Sandell-Hay
- 2 mins
- 17 June 2026 11:36 (AEST)
Memphasys lands national Monash IVF supply deal for Felix system
Memphasys has secured a 12-month exclusive national supply agreement with Monash IVF for its Felix sperm…
- Seja Al Zaidi
- 2 mins
- 16 June 2026 11:45 (AEST)
Paradigm clears key Phase 3 hurdle as osteoarthritis trial enrolment completes
Paradigm Biopharmaceuticals has completed enrolment in its pivotal Phase 3 osteoarthritis trial, with top-line results due…
- Seja Al Zaidi
- 2 mins
- 15 June 2026 12:02 (AEST)
Echo IQ teams up with Mayo Clinic to evaluate AI cardiac risk tool in cancer patients
Echo IQ has secured a research collaboration with Mayo Clinic to evaluate its AI-powered cardiac risk…
- Seja Al Zaidi
- 2 mins
- 12 June 2026 11:50 (AEST)
